Dr. Jonathan D. Ruzi, M.D.
Pulmonology (Pulmonary Disease Physician)
9060 E Via Linda Ste 250
Scottsdale, AZ 85258
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Js Weill Medical College, Cornell University (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,544
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: Js Weill Medical College, Cornell University
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
AZ license 22430 -
Sleep Medicine (Internal Medicine) Physician
AZ license 22430
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Honorhealth Scottsdale Shea Medical Center Scottsdale, AZ
- Honorhealth Scottsdale Thompson Peak Med Ctr Scottsdale, AZ
Medical groups
- Arizona Pulmonary Specialists LTD (43 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,544
- Services billed
- 6,033
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,873 | 1,101 |
| Test to measure expiratory airflow and volume | 1,099 | 696 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 464 | 69 |
| Test to measure the level of nitric oxide gas | 259 | 174 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 221 | 115 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 213 | 178 |
| New patient office or other outpatient visit, 45-59 minutes | 196 | 196 |
| Test to examine how well the lungs exchange gases | 155 | 148 |
| Blood count, hemoglobin | 155 | 148 |
| Test to determine lung volumes using sensors | 150 | 143 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Scottsdale, AZ | 449 |
| Montelukast Sodium Other prescribers in Scottsdale, AZ | 390 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Scottsdale, AZ | 165 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Scottsdale, AZ | 151 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Scottsdale, AZ | 141 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Scottsdale, AZ | 110 |
| Arnuity Ellipta (fluticasone furoate) Other prescribers in Scottsdale, AZ | 103 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Scottsdale, AZ | 79 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Scottsdale, AZ | 73 |
| Prednisone Other prescribers in Scottsdale, AZ | 72 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 87 payments worth $1,808 in total to this clinician.
| GlaxoSmithKline, LLC. | $247 |
|---|---|
| Viiv Healthcare Company | $238 |
| Insmed, Inc. | $225 |
| AstraZeneca Pharmaceuticals LP | $211 |
| Viatris Specialty LLC | $108 |
| Verona Pharma, Inc. | $97.84 |
| United Therapeutics Corporation | $85.82 |
| Regeneron Healthcare Solutions, Inc. | $77.96 |
| Food and Beverage | $1,808 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.